The tumour histopathology "glossary" for AI developers

PLoS Comput Biol. 2025 Jan 23;21(1):e1012708. doi: 10.1371/journal.pcbi.1012708. eCollection 2025 Jan.

Abstract

The applications of artificial intelligence (AI) and deep learning (DL) are leading to significant advances in cancer research, particularly in analysing histopathology images for prognostic and treatment-predictive insights. However, effective translation of these computational methods requires computational researchers to have at least a basic understanding of histopathology. In this work, we aim to bridge that gap by introducing essential histopathology concepts to support AI developers in their research. We cover the defining features of key cell types, including epithelial, stromal, and immune cells. The concepts of malignancy, precursor lesions, and the tumour microenvironment (TME) are discussed and illustrated. To enhance understanding, we also introduce foundational histopathology techniques, such as conventional staining with hematoxylin and eosin (HE), antibody staining by immunohistochemistry, and including the new multiplexed antibody staining methods. By providing this essential knowledge to the computational community, we aim to accelerate the development of AI algorithms for cancer research.

MeSH terms

  • Algorithms
  • Artificial Intelligence*
  • Computational Biology* / methods
  • Deep Learning*
  • Humans
  • Immunohistochemistry
  • Neoplasms* / pathology
  • Tumor Microenvironment* / physiology

Grants and funding

TAG and AMB are funded by Cancer Research UK (DRCNPG-May21_100001). KB was funded by the Swiss National Science Foundation (P500PM_217647 / 1). SM acknowledges funding from the Institute of Cancer Research's Data Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.